Tramadol Synteza

Quick links

Choose a section

Quick links to important sections

Advertisements

Tramadol Synteza

Advertisements
Advertisements

Treatment option: Pain, Chronic Pain

Advertisements

Overview of Tramadol Synteza

Tramadol Synteza is a pharmaceutical product primarily defined by its active ingredient, Tramadol Hydrochloride, a synthetic compound structurally related to codeine, which serves as a highly effective centrally acting analgesic for the management of pain. The medicine is primarily used to address significant or persistent discomfort.

Property Description
Active Ingredient Tramadol Hydrochloride
Form Tablet, Capsule, Oral Solution, Injection
Pharmacological Class Opioid Analgesic, Centrally Acting Analgesic
General Use Relief of moderate to severe pain
Origin Synthetic

What Type of Medicine is Tramadol Synteza?

Tramadol Synteza is classified as an opioid analgesic, a pharmacological category of medications that operate on the central nervous system to alleviate pain perception. The active component, Tramadol, functions as a racemate—a mixture of two enantiomers—a differentiating feature from some other opioid compounds. Tramadol is an opioid agonist indicated for pain management in adults.

Tramadol's Unique Approach to Pain Relief

The general purpose of Tramadol Synteza is to provide robust relief for moderate to severe pain by utilizing a dual action effect, which sets it apart from conventional analgesics. This multi-modal mechanism involves the binding of the compound to specific mu-opioid receptors in the central nervous system, and it also acts as an inhibitor of the reuptake of the neurotransmitters norepinephrine and serotonin. This combined pharmacological activity enhances inhibitory effects on pain transmission. Therefore, the medicine helps mitigate discomfort by targeting two distinct pathways involved in how the body processes pain signals.

Composition and Physical Forms of Tramadol Hydrochloride

The medication is a single-ingredient product whose therapeutic activity relies exclusively on Tramadol Hydrochloride. In clinical practice, this compound is prepared in various standard dosage form(s), including oral preparations like tablets and capsules, as well as specialized injectable solutions. This versatility allows for the drug to be administered via the oral or parenteral routes, utilizing a solid matrix or an aqueous solution as a base/vehicle, combined with pharmaceutical excipients necessary for stability and proper delivery.

Regulatory References

  1. FDA DailyMed Label for Tramadol Hydrochloride
Advertisements

What side effects are possible with Tramadol Synteza?

Possible Side Effects and Safety Information

Tramadol Synteza’s safety profile, based on Tramadol Hydrochloride, is organized according to regulatory classifications to communicate potential risks. Adverse reactions are classified by frequency and grouped by the body systems they affect.


Frequency of Adverse Reactions

Adverse reactions are classified according to official frequency standards:

Classification Examples of Reactions
Very Common (ge 1/10) Nausea, Dizziness, Somnolence
Common (ge 1/100 to < 1/10) Vomiting, Constipation, Dry mouth, Headache, Sweating
Rare (ge 1/10,000 to < 1/1,000) Seizures, Hallucinations, Respiratory depression

These effects involve various System-Organ Classes, including Gastrointestinal disorders (e.g., Nausea, Constipation), Nervous system disorders (e.g., Dizziness, Seizures), and Psychiatric disorders (e.g., Confusion, Dependence).


Serious Adverse Reactions and Safety Constraints

Official labeling emphasizes several serious risks. These include the potential for Life-Threatening Respiratory Depression and the risk of Serotonin Syndrome when used with other serotonergic medicines. The risk of Addiction, Abuse, and Misuse is also prominently documented.

Safety Constraints note that use is contraindicated in children under 12 years and restricted in specific patient groups, such as those with uncontrolled epilepsy or severe hepatic or renal impairment. Common side effects like Nausea and Dizziness are often reported during the initial phase of treatment or when the dose is increased, while dependence is a risk associated with long-term exposure.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help: Regulatory Guidance

Overdose involving Tramadol Synteza is a severe medical emergency that requires immediate medical attention and necessitates contacting emergency services without delay. The official regulatory profile describes acute intoxication primarily affecting the central nervous system (CNS) and the respiratory system.

Documented Overdose Manifestations

Category Documented Regulatory Signs
CNS Effects Respiratory depression, Seizures (convulsions), Miosis (pinpoint pupils), and Coma.
Cardiovascular Effects Hypotension, Tachycardia, and Circulatory collapse.
Severe Complications Respiratory arrest, Fatal outcomes, and Serotonin Syndrome.

Officially Mandated Emergency Actions

The most serious risk is life-threatening respiratory depression. Management focuses on symptomatic and supportive treatment, including the maintenance of a patent airway and ventilatory support. Naloxone, an opioid antagonist, may be used to counteract respiratory depression; however, its effect on seizures may be limited. Regulatory sources note that patients with renal or hepatic impairment and elderly individuals may be at increased risk of severe toxicity. Suspected overdose requires continuous monitoring of vital signs within a hospital setting.

Advertisements

Therapeutic Uses of Tramadol Synteza

The medication is commonly used to help with symptoms related to moderate to severe physical discomfort. It is applied across domains where additional symptomatic support is needed to address symptoms that interfere with daily functioning.


What Tramadol Synteza Treats: Main Uses and Benefits

Tramadol Synteza is applicable in addressing a range of conditions characterized by heightened symptoms, including chronic lower back pain, certain pain presentations of osteoarthritis, and acute episodes like postoperative pain. It is relevant for easing distress in situations where patients experience either pain that begins suddenly or persistent discomfort associated with episodic or fluctuating manifestations. The medicine is commonly used to help with symptoms related to physical discomfort that escalate beyond what non-opioid pain relievers may effectively manage. It provides support that helps ease the overall symptom burden when symptoms become difficult to tolerate, assists with supporting functional stability and contributes to easing day-to-day comfort.

Summary of Therapeutic Context
Primarily used for moderate to severe pain intensity, and is relevant in both acute and chronic therapeutic contexts.

Regulatory References

  1. MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Official Population Eligibility for Tramadol Synteza

Tramadol Synteza is officially approved for use in adults 18 years and older when alternative pain treatments are inadequate. Regulatory documents strictly define the populations who must not use the medicine (contraindications) and those for whom use is restricted.

Contraindicated Populations Restriction Wording
Children younger than 12 years of age Contraindicated (Absolute Prohibition)
Children younger than 18 years after tonsillectomy/adenoidectomy Contraindicated
Patients with acute or severe bronchial asthma Contraindicated
Patients with known gastrointestinal obstruction (e.g., paralytic ileus) Contraindicated
Patients using MAO inhibitors (or within 14 days) Contraindicated

Age-Related and Conditional Rules:

Adolescents (12–18 years) with specific risk factors for breathing problems, such as obesity or obstructive sleep apnea, should avoid use. Older adults (over 75 years) are advised to use the medicine with greater caution.

Condition-Specific Limitations:

Use is not recommended/avoided for patients with severe renal impairment (creatinine clearance < 30 mL/min) and for extended-release formulations in patients with severe hepatic impairment. Use during breastfeeding is not recommended as the substance passes into breast milk.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Tramadol's dual mechanism of action—as an opioid and a weak inhibitor of serotonin and norepinephrine reuptake—gives it a complex interaction profile that involves both pharmacodynamic (additive effects) and pharmacokinetic (metabolism-based) concerns.

Contraindicated and Serious Combinations

  • Monoamine Oxidase Inhibitors (MAOIs): Concomitant use is contraindicated, or within 14 days of taking an MAOI, due to the high risk of Serotonin Syndrome and severe adverse events. Serotonin Syndrome is a potentially life-threatening condition caused by excessive serotonin levels.
  • CNS Depressants: Combining tramadol with central nervous system (CNS) depressants, including benzodiazepines, alcohol, hypnotics, and sedatives, may result in profound sedation, respiratory depression, coma, and death.

Interactions Affecting Metabolism and Efficacy

Tramadol is metabolized by the liver enzymes CYP2D6 and CYP3A4. Medications that inhibit or induce these enzymes can alter the concentrations of tramadol and its active metabolite, M1, leading to decreased pain relief or increased risk of adverse effects.

  • CYP2D6 Inhibitors (e.g., fluoxetine, quinidine): May increase tramadol exposure while decreasing the more potent M1 metabolite, potentially reducing analgesia and increasing seizure risk.
  • CYP3A4 Inducers (e.g., carbamazepine, rifampin): May reduce tramadol exposure, potentially resulting in decreased pain relief.
  • Serotonergic Drugs: Co-administration with other serotonergic agents (e.g., SSRIs, SNRIs, triptans, tricyclic antidepressants) increases the risk of Serotonin Syndrome and seizures.
  • Other Opioids: Concomitant use with mixed agonist/antagonist opioids (e.g., buprenorphine, nalbuphine) may reduce the analgesic effect.
Advertisements

Mechanism of Action

Tramadol Synteza functions through a dual-acting pharmacodynamic mechanism primarily targeting central nervous system signaling. The parent compound, tramadol, exhibits weak agonism at the mu-opioid receptor (mu-OR). This interaction modulates mu-OR activity, which is a G protein-coupled receptor linked to the G i/ o protein. mu-OR activation inhibits adenylyl cyclase, decreasing intracellular levels of cyclic adenosine monophosphate (cAMP), leading to the hyperpolarization of neurons and reduced neurotransmitter release.

the

Simultaneously, tramadol and its primary active metabolite, O-desmethyltramadol, act as inhibitors of the reuptake of norepinephrine (NE) and serotonin (5-HT) within the synaptic cleft of descending inhibitory pathways. Inhibition of the NE and 5-HT transporters (NET and SERT, respectively) increases the synaptic concentration and dwelling time of these monoamine neurotransmitters. This augmentation of monoaminergic signaling in the spinal cord and periaqueductal gray contributes to system-level modulation of afferent sensory signal transmission. The combined mu-OR agonism and monoamine reuptake inhibition defines the drug's mechanism.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Tramadol Synteza is taken orally and must be used at the lowest effective dosage for the shortest duration consistent with individual treatment goals. It is available in immediate-release (IR) and extended-release (ER) forms, each with a distinct dosing regimen and procedural rule set. The medication may be taken with or without food.

Dosing and Frequency

Formulation Standard Dosing (Adults) Maximum Daily Dose Frequency
Immediate-Release (IR) 50 mg to 100 mg as needed 400 mg Every 4 to 6 hours
Extended-Release (ER) 100 mg once daily (initial) 300 mg Once a day

Procedural Instructions

Extended-release capsules or tablets must be swallowed whole with liquid and must not be cut, crushed, chewed, split, or dissolved. The use of Tramadol Synteza is contraindicated in children younger than 12 years of age, and in children younger than 18 years of age following tonsillectomy and/or adenoidectomy.

Administration Adjustments

Dosage adjustments are required for certain patient populations:

  • Patients Over 75 Years (IR): The total maximum daily dose should not exceed 300 mg.
  • Severe Renal Impairment (CrCl < 30 mL/min): For the IR formulation, the dosing interval is increased to 12 hours, and the maximum daily dose is limited to 200 mg. The ER formulation is generally not recommended in this group.
  • Severe Hepatic Impairment: The recommended IR dose is 50 mg every 12 hours. The ER formulation is not recommended in cases of severe impairment.
Advertisements

Recent Clinical Evidence

Evidence for Use in Chronic Pain Conditions

Studies using the active ingredient of Tramadol Synteza was evaluated in research exploring how symptoms change over time in conditions marked by functional limitations. This research involves Randomized Controlled Trials (RCTs) and Systematic Reviews for conditions like osteoarthritis and chronic low back pain. Researchers examined outcomes reflecting daily functioning and symptom intensity over defined time intervals. However, when aggregated, the magnitude of the differences reported in physical discomfort measurements was frequently observed to be limited across the pooled trials, and the certainty remains low due to the high risk of bias in underlying studies.


Evidence for Use in Acute Pain Situations

The active ingredient was observed in studies conducted during periods of increased symptom activity, such as research exploring short-term symptom changes following surgical procedures. These RCTs focused on immediate response, tracking how quickly pain levels shifted after administration and the need for additional relief. Findings describing short-term patterns were observed compared to placebo, but comparisons to other active treatments showed significant variability across different studies. Evidence highlights what is known but long-term effects are not fully established beyond the initial acute phase.


Research Gaps and Uncertainties

The majority of evidence was observed in studies where follow-up durations were limited, typically lasting only a few weeks to months. This limited timeframe offers insufficient data to fully characterize outcomes over extended periods. Furthermore, the results apply only to the populations studied, with data for certain groups remain insufficient, particularly older adults and individuals with complex conditions. Subgroup findings are uncertain, meaning the consistency of findings across different pain types is not definitively established.

Key Studies & References Tramadol Hydrochloride Tablets: FDA Prescribing Information

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Tramadol Synteza (FAQ)

Q: What is the main purpose of Tramadol Synteza?

A: Tramadol Synteza is a prescription medication indicated for the management of moderate to moderately severe pain in adults. It is classified as an opioid agonist.

Q: How does Tramadol Synteza compare to non-opioid pain relievers?

A: Research indicates that Tramadol Synteza is effective for pain management and may be considered when non-opioid treatments do not sufficiently control pain. Studies have observed its use in various pain settings, but direct comparative superiority to all non-opioid options is not generally asserted without specific clinical trial context.

Q: Is there a risk of developing dependence on Tramadol Synteza?

A: The use of Tramadol Synteza carries a risk of developing physical dependence and addiction. It is important to discuss this risk with a healthcare provider. Following the prescribed guidance is essential to help manage this potential risk.

Q: What are the possible side effects associated with Tramadol Synteza?

A: Common side effects that may be experienced include nausea, dizziness, constipation, and headache. Serious side effects, though less frequent, can occur, such as seizure or serotonin syndrome. Patients are generally advised to discuss all potential side effects and concerns with their prescribing physician.

Q: Is Tramadol Synteza approved for use in children?

A: Tramadol Synteza is generally not indicated for use in children, and specific age-related restrictions apply. The prescribing information typically notes that it is intended for use in adults for pain management.

Q: Does food intake affect how Tramadol Synteza works?

A: The absorption and function of the medication may or may not be influenced by food intake, depending on the specific formulation (e.g., immediate-release versus extended-release). Patients are usually advised to follow the specific instructions provided by the pharmacist or prescribing physician regarding administration relative to meals.

Q: Are there specific populations where the use of Tramadol Synteza is cautioned?

A: Healthcare providers often exercise caution when considering Tramadol Synteza for individuals with a history of substance abuse, seizure disorders, or severe breathing problems. Additionally, dose adjustments may be necessary for patients with significant kidney or liver impairment. It is important for patients to provide a complete medical history to their provider.

Q: Can Tramadol Synteza interact with other medications?

A: Yes, Tramadol Synteza can interact with many other medicines, including certain antidepressants (SSRIs, SNRIs), MAO inhibitors, and other opioid medications. These interactions could potentially increase the risk of serious conditions like serotonin syndrome or respiratory depression. A comprehensive review of all current medications, including over-the-counter drugs and supplements, is generally required before initiating therapy.

Advertisements

How should Tramadol Synteza be stored and disposed of?

Storage and Disposal Requirements

Tramadol Synteza (Tramadol Hydrochloride) must be stored at controlled room temperature, specifically between 20°C to 25°C (68°F to 77°F). It is required that the medicine be dispensed in a tight container and the container must be kept tightly closed to maintain product stability and prevent contamination.

Mandatory Safety and Disposal

For safety, the medication must be kept out of reach of children at all times, as accidental ingestion of even one dose can result in a fatal overdose. Unused or expired medication should be disposed of using a drug take-back program when available. If a take-back program is not accessible, the official procedure is to mix the tablets with an undesirable substance, such as dirt or used coffee grounds, seal the mixture in a plastic bag, and place it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tramadol Synteza found in:

A-Z Index: